Transcription of Imfinzi Full Prescribing Information
{{id}} {{{paragraph}}}
Example: air traffic controller
Imfinzi Full Prescribing Information
US-56097 HIGHLIGHTS OF Prescribing INFORMATIONT hese highlights do not include all the Information needed to use Imfinzi safely and effectively. See full Prescribing Information for (durvalumab) injection, for intravenous use Initial Approval: 2017--------------------------------- RECENT MAJOR CHANGES--------------------------------- Indications and Usage, Urothelial Carcinoma Accelerated ApprovalIndication Removed (1) 02/2021 Dosage and Administration ( ) 02/2021 Dosage and Administration, Dosage Modifications ( ) 11/2020 Dosage and Administration ( ) 07/2021 Warnings and Precautions ( , ) 11/2020 Warnings and Precautions ( ) 07/2021--------------------------------- INDICATIONS AND USAGE --------------------------------- Imfinzi is a programmed death-ligand 1 (PD-L1) blocking antibody indicated: for the treatment of adult patients with unresectable, Stage III non-small cell lung cancer (NSCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy.
transplant rejection. ... non-small cell lung cancer (NSCLC) whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy. 1.2 Small Cell Lung Cancer. IMFINZI, in combination with etoposide and either carboplatin or cisplatin, is .
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: